- Home
- FORA vs RENB Comparison
FORA vs RENB Comparison
Compare FORA & RENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FORA
- RENB
- Stock Information
- Founded
- FORA 2014
- RENB 2011
- Country
- FORA United States
- RENB United States
- Employees
- FORA N/A
- RENB N/A
- Industry
- FORA Computer Software: Prepackaged Software
- RENB Biotechnology: Pharmaceutical Preparations
- Sector
- FORA Technology
- RENB Health Care
- Exchange
- FORA Nasdaq
- RENB Nasdaq
- Market Cap
- FORA 66.1M
- RENB 62.0M
- IPO Year
- FORA N/A
- RENB N/A
- Fundamental
- Price
- FORA $2.05
- RENB $0.27
- Analyst Decision
- FORA Strong Buy
- RENB
- Analyst Count
- FORA 1
- RENB 0
- Target Price
- FORA $5.00
- RENB N/A
- AVG Volume (30 Days)
- FORA 7.5K
- RENB 2.2M
- Earning Date
- FORA 08-13-2025
- RENB 05-15-2025
- Dividend Yield
- FORA N/A
- RENB N/A
- EPS Growth
- FORA N/A
- RENB N/A
- EPS
- FORA N/A
- RENB N/A
- Revenue
- FORA $22,332,001.00
- RENB N/A
- Revenue This Year
- FORA $46.25
- RENB N/A
- Revenue Next Year
- FORA $11.30
- RENB N/A
- P/E Ratio
- FORA N/A
- RENB N/A
- Revenue Growth
- FORA 5.22
- RENB N/A
- 52 Week Low
- FORA $1.85
- RENB $0.27
- 52 Week High
- FORA $4.03
- RENB $2.10
- Technical
- Relative Strength Index (RSI)
- FORA 49.88
- RENB 38.03
- Support Level
- FORA $1.96
- RENB $0.33
- Resistance Level
- FORA $2.21
- RENB $0.32
- Average True Range (ATR)
- FORA 0.12
- RENB 0.03
- MACD
- FORA 0.00
- RENB -0.00
- Stochastic Oscillator
- FORA 33.33
- RENB 4.84
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.